Pyridine- and quinoline-derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/38 (2006.01) A61K 31/435 (2006.01) A61K 31/47 (2006.01) A61P 1/04 (2006.01) A61P 3/10 (2006.01) C07D 221/00 (2006.01) C07D 221/16 (2006.01) C07D 307/00 (2006.01) C07D 311/00 (2006.01) C07D 333/00 (2006.01) C07D 335/00 (2006.01) C07D 491/04 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2474460

The present invention relates to compounds of formula (I), wherein R1, R2, R3 and R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

L'invention concerne des composés de formule générale (I), dans laquelle R<l>, R<2>, R<3> et R<4 >ont la signification indiquée dans la description et dans les revendications, ainsi que des sels pharmaceutiquement acceptables de ceux-ci. Ces composés sont utiles dans le traitement et/ou la prophylaxie de maladies associées au DPP IV, de type diabète, en particulier le diabète insulino-dépendant, et la diminution de la tolérance au glucose.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyridine- and quinoline-derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridine- and quinoline-derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine- and quinoline-derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2028557

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.